Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinwang Duan

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Rheumatology and Immunology Research|July 3, 2025
Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort studyWei Bai, Liying Peng, Yinli Gui, et al.
Clinical Rheumatology|November 16, 2022
Renal tubular acidosis and associated factors in patients with primary Sjögren's syndrome: a registry-based studyYuying Zhang, Lin Qiao, Liyun Zhang, et al.
Arthritis Research & Therapy|March 13, 2024
Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort studyJun Li, Liying Peng, Lijun Wu, et al.
RMD Open|September 23, 2024
Predicting the risk of cardiovascular and cerebrovascular event in systemic lupus erythematosus: a Chinese SLE treatment and research group study XXVICan Huang, Yutong Li, Ziqian Wang, et al.
Arthritis Research & Therapy|May 12, 2023
Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXIICheng Cheng, Can Huang, Zhen Chen, et al.
Clinical and Experimental Rheumatology|March 31, 2018
Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritisChen Yu, Mengtao Li, Xinwang Duan, et al.
Annals of the Rheumatic Diseases|August 23, 2025
Mycophenolate mofetil plus methotrexate versus cyclophosphamide with sequential azathioprine for treatment of Takayasu arteritisXiaochuan Sun, Jing Li, Xinwang Duan, et al.
Frontiers in Medicine|October 7, 2022
Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosusYue Shi, Dandan Bi, Yanhong Wang, et al.
Chinese Medical Journal|December 16, 2022
Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVIIYinli Gui, Wei Bai, Jian Xu, et al.
Clinical Rheumatology|May 16, 2025
Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional studyMinhui Wang, Jiaxin Zhou, Feng Zhan, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Rheumatology and Immunology Research|July 3, 2025
Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort studyWei Bai, Liying Peng, Yinli Gui, et al.
Clinical Rheumatology|November 16, 2022
Renal tubular acidosis and associated factors in patients with primary Sjögren's syndrome: a registry-based studyYuying Zhang, Lin Qiao, Liyun Zhang, et al.
Arthritis Research & Therapy|March 13, 2024
Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort studyJun Li, Liying Peng, Lijun Wu, et al.
RMD Open|September 23, 2024
Predicting the risk of cardiovascular and cerebrovascular event in systemic lupus erythematosus: a Chinese SLE treatment and research group study XXVICan Huang, Yutong Li, Ziqian Wang, et al.
Arthritis Research & Therapy|May 12, 2023
Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXIICheng Cheng, Can Huang, Zhen Chen, et al.
Clinical and Experimental Rheumatology|March 31, 2018
Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritisChen Yu, Mengtao Li, Xinwang Duan, et al.
Annals of the Rheumatic Diseases|August 23, 2025
Mycophenolate mofetil plus methotrexate versus cyclophosphamide with sequential azathioprine for treatment of Takayasu arteritisXiaochuan Sun, Jing Li, Xinwang Duan, et al.
Frontiers in Medicine|October 7, 2022
Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosusYue Shi, Dandan Bi, Yanhong Wang, et al.
Chinese Medical Journal|December 16, 2022
Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVIIYinli Gui, Wei Bai, Jian Xu, et al.
Clinical Rheumatology|May 16, 2025
Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional studyMinhui Wang, Jiaxin Zhou, Feng Zhan, et al.
Pageof 8